ACADIA Pharmaceuticals to Present at Two Upcoming Virtual Investor Conferences
BofA Securities Health Care Conferenceon Tuesday, May 12, 2020, at 11:00 a.m. Eastern Time.
RBC Capital Markets Global Healthcare Conferenceon Tuesday, May 19, 2020, at 1:55 p.m. Eastern Time.
These conferences will both be held virtually. Live webcasts of ACADIA’s presentations will be accessible on the company’s website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website for approximately one month following each presentation.
ACADIA is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders. ACADIA has developed and commercialized the first and only medicine approved for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. ACADIA also has ongoing clinical development efforts in additional areas with significant unmet need, including dementia-related psychosis, major depressive disorder, the negative symptoms of schizophrenia, and Rett syndrome. This press release and further information about ACADIA can be found at: www.acadia-pharm.com.